Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0ZN1R
|
||||
| Former ID |
DIB002861
|
||||
| Drug Name |
Delphinidin
|
||||
| Synonyms |
IdB-1056; 3,3',4',5,5',7-Hexahydroxy-2-phenylbenzopyrylium chloride; 3,3',4',5,5',7-Hexahydroxyflavylium chloride;3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-1-benzopyrilium chloride
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cardiovascular disorder [ICD10:I00-I99] | Phase 2 | [527896] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H11O7+
|
||||
| Canonical SMILES |
Oc1cc(O)c2cc(O)c([o+]c2c1)c3cc(O)c(O)c(O)c3
|
||||
| InChI |
1S/C15H10O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-5H,(H5-,16,17,18,19,20,21)/p+1
|
||||
| InChIKey |
JKHRCGUTYDNCLE-UHFFFAOYSA-O
|
||||
| CAS Number |
CAS 528-53-0
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | Modulator | [527896] | |
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.